Literature DB >> 11567084

A directed approach to improving the solubility of Moloney murine leukemia virus reverse transcriptase.

D Das1, M M Georgiadis.   

Abstract

One of the difficulties that can impede structural work on a molecule of interest is limited solubility. Although functionally similar to the human immunodeficiency virus type-1 reverse transcriptase (HIV-1 RT), the Moloney murine leukemia virus reverse transcriptase (MMLV RT) differs both in architecture and solubility properties. Reverse transcriptase is an essential retroviral enzyme that replicates the single-stranded RNA genome of the retrovirus producing a double-stranded DNA copy, which is subsequently integrated into the host's genome. We have introduced a single amino acid substitution in the connection domain of an N-terminally truncated MMLV RT (L435K) that significantly improves the solubility of the enzyme eliminating the need for nonionic detergents in buffering storage solutions. The substituted enzyme retains near wild-type polymerase activity. An important consequence of the improved solubility of the L435K MMLV RT has been the ability to obtain diffraction quality crystals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11567084      PMCID: PMC2374227          DOI: 10.1110/ps.16301

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  13 in total

1.  Evaluation of PSI-BLAST alignment accuracy in comparison to structural alignments.

Authors:  I Friedberg; T Kaplan; H Margalit
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

2.  Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase.

Authors:  Z N Yang; T C Mueser; F D Bushman; C C Hyde
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

3.  Purification, solution properties and crystallization of SIV integrase containing a continuous core and C-terminal domain.

Authors:  Y Li; Y Yan; J Zugay-Murphy; B Xu; J L Cole; M Witmer; P Felock; A Wolfe; D Hazuda; M K Sardana; Z Chen; L C Kuo; V V Sardana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-11

4.  GenTHREADER: an efficient and reliable protein fold recognition method for genomic sequences.

Authors:  D T Jones
Journal:  J Mol Biol       Date:  1999-04-09       Impact factor: 5.469

5.  Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues.

Authors:  T M Jenkins; A B Hickman; F Dyda; R Ghirlando; D R Davies; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

6.  Use of an N-terminal fragment from moloney murine leukemia virus reverse transcriptase to facilitate crystallization and analysis of a pseudo-16-mer DNA molecule containing G-A mispairs.

Authors:  M L Coté; S J Yohannan; M M Georgiadis
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-09

7.  Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.

Authors:  S Najmudin; M L Coté; D Sun; S Yohannan; S P Montano; J Gu; M M Georgiadis
Journal:  J Mol Biol       Date:  2000-02-18       Impact factor: 5.469

8.  Substitution of Asp114 or Arg116 in the fingers domain of moloney murine leukemia virus reverse transcriptase affects interactions with the template-primer resulting in decreased processivity.

Authors:  J Gu; R A Villanueva; C S Snyder; M J Roth; M M Georgiadis
Journal:  J Mol Biol       Date:  2001-01-12       Impact factor: 5.469

9.  Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli.

Authors:  M J Roth; N Tanese; S P Goff
Journal:  J Biol Chem       Date:  1985-08-05       Impact factor: 5.157

10.  Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.

Authors:  L A Kohlstaedt; J Wang; J M Friedman; P A Rice; T A Steitz
Journal:  Science       Date:  1992-06-26       Impact factor: 47.728

View more
  12 in total

1.  Synthetic and natural consensus design for engineering charge within an affibody targeting epidermal growth factor receptor.

Authors:  Brett A Case; Benjamin J Hackel
Journal:  Biotechnol Bioeng       Date:  2016-02-04       Impact factor: 4.530

2.  Amino acid contribution to protein solubility: Asp, Glu, and Ser contribute more favorably than the other hydrophilic amino acids in RNase Sa.

Authors:  Saul R Trevino; J Martin Scholtz; C Nick Pace
Journal:  J Mol Biol       Date:  2006-10-13       Impact factor: 5.469

3.  Frozen master mix-based modification of commercial reverse transcriptase PCR for detection of influenza and respiratory syncytial viruses.

Authors:  Brooke Wenninger; Erik Munson; Maureen Napierala; Kimber L Munson; Dorothy Bilbo; Jeanne E Hryciuk
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

4.  Protein Crystal Engineering of YpAC-IV using the Strategy of Excess Charge Reduction.

Authors:  D Travis Gallagher; N Natasha Smith; Sook-Kyung Kim; Howard Robinson; Prasad T Reddy
Journal:  Cryst Growth Des       Date:  2009-08-05       Impact factor: 4.076

5.  Engineered CRISPR prime editors with compact, untethered reverse transcriptases.

Authors:  Julian Grünewald; Bret R Miller; Regan N Szalay; Peter K Cabeceiras; Christopher J Woodilla; Eliza Jane B Holtz; Karl Petri; J Keith Joung
Journal:  Nat Biotechnol       Date:  2022-09-26       Impact factor: 68.164

6.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

7.  Rational improvement of simvastatin synthase solubility in Escherichia coli leads to higher whole-cell biocatalytic activity.

Authors:  Xinkai Xie; Inna Pashkov; Xue Gao; Jennifer L Guerrero; Todd O Yeates; Yi Tang
Journal:  Biotechnol Bioeng       Date:  2009-01-01       Impact factor: 4.530

Review 8.  Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase.

Authors:  Marie L Coté; Monica J Roth
Journal:  Virus Res       Date:  2008-02-21       Impact factor: 3.303

9.  Crystal structure of xenotropic murine leukaemia virus-related virus (XMRV) ribonuclease H.

Authors:  Ju Hee Kim; Sunghyun Kang; Suk-Kyeong Jung; Keum Ran Yu; Sang J Chung; Bong Hyun Chung; Raymond L Erikson; Bo Yeon Kim; Seung Jun Kim
Journal:  Biosci Rep       Date:  2012-10       Impact factor: 3.840

10.  Novel mutations in Moloney Murine Leukemia Virus reverse transcriptase increase thermostability through tighter binding to template-primer.

Authors:  Bahram Arezi; Holly Hogrefe
Journal:  Nucleic Acids Res       Date:  2008-12-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.